 

I'UUID‘531.28%:-9AF9C-4572-BSlD-BAF0F6C7§BZF

8- Md cted I
IIIIIIIIIII II IIlllllIllIIlIIIIlIIlIIIIIlIIIIIIIIIlllllIIll I
ll

IIlllll ”II
I IIIII IIIIIIIIIIIIIIIIIIIIIIII
IIIIIIIIIIIHIIIIIII IIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII I

Clinical Case Report I: W) O
(For Collection of Cancerous Tissue) (va, manna

99735
533‘ 5%))“ N05 @ 9
”Hm €50}!

nformed Consent Ly) 11/213115

 

 

 

 

 

I personally informed this patient that a specimcn(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

Name of Physician or Study Coordinator gignature I Date

 

[Clinical Informatiorl

 

 

 

 

 

 

GENERAL INFORMATION
Dot-eofBirth (mm) Height _ MgrltalShtul Tern magnum
‘, 7 , m __ :2 Single )sanied term/mesa
Léender Weight :1 Divorced. c3 Widow Blood Pressure Heart Rate
[:1 Male Wemale

 

 

 

 

 

 

 

HISTORY OF PRESENT ILLNESS
Chief Complaints' A, ICU-W W W‘% W IQM4“) PM “TIM

Svmvmms= 4/2W Wags ﬂawed in «eh m {away}—
Clinical Findings:

 

 

 

 

Performance Scale (Karnofsky Score):
a 100 Asymptomatic a 80.90 Symptomatic but Fully Ambulatory M6040 Symptomatic, in bed less than 50% of day
:1 40-50 Symptomatic, in bed more than 50% of day, but not bed ridden a 20-30 Bed Ridden

 

 

 

CURRENT MEDICATIONS

 

PAST MEDICAL HISTORY

 

 

 

 

 

 

 

OB/GYN HISTORY .
Menopausal Status Date of First Mensee_ # of Pregnancies
D Pro-menopausal. 0 g
n Peri-Menopausal Date 07 Last Menses # of five Births
«pPost-menopausal 5) ?

 

 

 

Birth Control: Cl Condom Cl Oral Contraceptive ? IUD

Cl Other:

 

Current Stems
0 YES NO

SOCIAL

 

RY

 

u Hormone Replacement
Therapy:

Duratlon

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA

Test Result 1 Date I I Test Result Date
HIV )9 Negative El Positive: ‘ CEA L'J Negative El Positive:

Hep B WNeEative Cl Positive: I ’ CA 15-3 D Negative :1 Positive:

Hep C WNegetive :1 Positive: CA 19-9 Cl Negative :1 Positive:
APP Ir13 Negative D Positive: PSA 0 Negative Cl Positive:

Other: :1 Negative :1 Positive: Other: {3 Negative :1 Positive:

BIT Cell Markers:

 

 

 

 

DIAGNOSTIC STUDIES
Results

Ultrasound
X-Ra
CT

MRI
Bi

CLINICAL DIAGNOSIS
Clinical

J.
Involved

Clinical
12 N2_ M0 Shae: EA»

Treatment Informationl
SURGICAL TREATMENT

 

 

 

Tumor

Extension

L 'Nodes

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes
Distant Metastasis

Detailed

 

Pathology Form

 

lSpecimen Informationl

 

 

 

 

 

 

 

 

 

 

 

 

Collected by: ___ Date: _Time:
Preserved by: __ Date: Time:
SPECIMENTYPE (# of samples provided)
Frozen Parafﬁn Block Blood/Serum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
,2 Z Z 2'. 2» a
Time to LNZ Time to Formalin Time to LN2
J ‘5 min / 4," min min

 

 

 

 

 

PATHOLOGICAL DESCRIPTION

Tumor

Size Extension

X X on

L Nodes
#

Distance to NAT
cm

Tumor

Distant Metastasis
Location

ical

Na Mo

Stage: ID:
jﬂ/ﬁe we: a (ﬁt-5,2242 5/ Mgew’ye :5)

PT2

 

 

 

 

 

Consolidated Pathology Diagnosis

 

Cellular Diﬂbrentlaﬂon: :1 Well

    

' Grade:
I / PE 9 f l 3 4' . pg 2 I
ﬁnal Fluid”! leggy}!

 
 

17:

 
  

 

Histological Diagnosir

 

Comments:

m,.. 07,: WeWmW/éﬂjﬂ #29 4/1/

 

 

 

Director, Research Pathology

INTEGRATED REPORT OF FINDINGS BY COLLABORATORS AND ’ATHOLOGIST’S - .

 

